Arginine

Generic Name: Arginine

Brand Names: Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, R-gene, Travasol 10, Trophamine 10 %

Drug Type: Small Molecule

Chemical Formula: C_₆H_₁₄N_₄O_₂

CAS Number: 74-79-3

Unique Ingredient Identifier: 94ZLA3W45F

Background: An essential amino acid that is physiologically active in the L-form.

Indication: Used for nutritional supplementation, also for treating dietary shortage or imbalance.

Associated Conditions: Acromegaly, Craniopharyngioma, Disorders of urea cycle metabolism, Gigantism, Hyperammonaemia, Hypophysectomy, Kidney Damage, Panhypopituitarism, Pituitary Dwarfism, Pituitary Neoplasms, Pituitary trauma, Problems of growth and stature

Associated Therapies: Nutritional supplementation, Amino acid supplementation

Clinical Trials

The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

Not Applicable

Terminated

Conditions: Diabetes Mellitus

First Posted Date: 2006-01-20

Last Posted Date: 2009-08-07

Lead Sponsor: Pfizer

Target Recruit Count: 29

Registration Number: NCT00280085

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

Treatment of Alcohol-Related Hepatitis With Arginine

Phase 2

Withdrawn

Conditions: Alcoholic Hepatitis

Interventions: Drug: Arginine

First Posted Date: 2005-09-20

Last Posted Date: 2013-03-12

Lead Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Registration Number: NCT00200746

Locations: 🇺🇸
Harbor - University of California Los Angeles Medical Center, Torrance, California, United States

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Completed

Conditions: Thalassemia
Osteoporosis
Iron Overload
Hypertension, Pulmonary
Anemia, Cooley's
Beta-Thalassemia
Hematologic Diseases

First Posted Date: 1999-10-28

Last Posted Date: 2014-03-04

Lead Sponsor: Carelon Research

Target Recruit Count: 1000

Registration Number: NCT00000623

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
🇺🇸
Children's Hospital Oakland, Oakland, California, United States

and more 2 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy